FDA Clearance Approved for GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform

GE HealthCare has announced US FDA 510(k) clearance for its CARESCAPE Canvas patient monitoring platform. 

“CARESCAPE Canvas provides a precise, standardised and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable,” said Dr Roland Schrewe, head of PICU, University of Frankfurt. 

GE HealthCare tested the bedside monitor with the rest of its ecosystem, not only with current devices but with prior versions used across the 100 million patients monitored by GE HealthCare devices each year. This will allow systems to upgrade to the latest capabilities in their own time.

Neal Sandy, general manager of monitoring solutions, GE HealthCare stated, “This new monitoring ecosystem has the potential for a hospital to have one unified approach to patient monitoring that can be easily tailored for each patient.” 

Recently awarded the prestigious iF Design Award 2023 for product design in medicine, CARESCAPE Canvas has been approved for use in the EU since June 2022 and is now cleared in the US.

Click here to read the original news story.